18F-Fluciclovine PET/CT Impact on Predicting Clinical Outcome of 177Lu-PSMA-617 Therapy in Patients With Prostate Cancer

Clinical trial NCT06706921 · RECRUITING

Trial details

NCT number: NCT06706921
Sponsor: VA Greater Los Angeles Healthcare System
Status: RECRUITING
Phase: Phase 4
Study type: INTERVENTIONAL

Prostatic Neoplasms Prostatic Neoplasms, Castration-Resistant Metastatic Prostate Cancer Male Urogenital Diseases Prostatic Diseases Urogenital Diseases, Male Genital Diseases, Male Neoplasms Neoplasms by Site Urogenital Neoplasms Genital Neoplasms, Male

Start date: 2024-12-15
Primary completion: 2027-11-01
Enrollment: 15

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.